Literature DB >> 28418550

Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction.

Alexander T Sandhu1, Daniel A Ollendorf1, Richard H Chapman1, Steven D Pearson1, Paul A Heidenreich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28418550     DOI： 10.7326/L17-0044

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.

Authors:  Derek S Chew; Zak Loring; Jatin Anand; Marat Fudim; Angela Lowenstern; Jennifer A Rymer; Kristin E D Weimer; Brett D Atwater; Adam D DeVore; Derek V Exner; Peter A Noseworthy; Clyde W Yancy; Daniel B Mark; Jonathan P Piccini
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-12-07

2.  Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.

Authors:  Justin T Parizo; Jeremy D Goldhaber-Fiebert; Joshua A Salomon; Kiran K Khush; John A Spertus; Paul A Heidenreich; Alexander T Sandhu
Journal:  JAMA Cardiol       Date:  2021-08-01       Impact factor: 30.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.